Detalhe da pesquisa
1.
Testing for t(3;8) in MYC/BCL6 re-arranged large B cell lymphoma identifies a high risk subgroup with inferior survival.
Blood
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38648564
2.
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry-equivocal invasive breast cancer.
Histopathology
; 81(4): 511-519, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879836
3.
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.
Histopathology
; 75(2): 225-235, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31017314
4.
In situ follicular neoplasia with translocation of BCL6 - a new variant with different immunohistochemical properties.
Br J Haematol
; 195(2): 154, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991335
5.
An international study to increase concordance in Ki67 scoring.
Mod Pathol
; 28(6): 778-86, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25698062
6.
The updated ASCO/CAP guideline recommendations for HER2 testing in the management of invasive breast cancer: a critical review of their implications for routine practice.
Histopathology
; 64(5): 609-15, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24382093
7.
Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ.
Histopathology
; 65(1): 2-8, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24267587
8.
UK recommendations for HER2 assessment in breast cancer: an update.
J Clin Pathol
; 76(4): 217-227, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564170
9.
Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study.
Cancers (Basel)
; 15(5)2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900303
10.
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.
Blood
; 112(9): 3807-17, 2008 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18599795
11.
A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISH.
Histopathology
; 56(3): 297-304, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20459530
12.
Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients.
Br J Haematol
; 142(6): 925-33, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18573109
13.
Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
J Clin Oncol
; 23(7): 1514-21, 2005 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15735127
14.
Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia.
Leuk Res
; 30(9): 1113-8, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16458962
15.
The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers and survival in multiple myeloma.
Leuk Lymphoma
; 47(2): 281-4, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16321858
16.
ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen.
J Thorac Oncol
; 11(12): 2241-2247, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27468935
17.
Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.
NPJ Breast Cancer
; 2: 16014, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28721378
18.
Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.
Oncogene
; 23(6): 1326-31, 2004 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-14961078
19.
Updated UK Recommendations for HER2 assessment in breast cancer.
J Clin Pathol
; 68(2): 93-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488926
20.
FKBPL: a marker of good prognosis in breast cancer.
Oncotarget
; 6(14): 12209-23, 2015 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25906750